Detalhe da pesquisa
1.
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.
Pharm Res
; 38(3): 503-513, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638122
2.
Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.
Pharm Res
; 38(2): 289-299, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515137
3.
The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice.
Biol Pharm Bull
; 43(6): 951-958, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32475917
4.
Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.
Chem Pharm Bull (Tokyo)
; 68(11): 1025-1033, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33132369
5.
Design and synthesis of curcumin derivatives as tau and amyloid ß dual aggregation inhibitors.
Bioorg Med Chem Lett
; 26(20): 5024-5028, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27624076
6.
Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Bioorg Med Chem Lett
; 20(5): 1721-3, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20137941
7.
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Bioorg Med Chem Lett
; 20(5): 1718-20, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20137934
8.
Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.
Int J Pharm
; 577: 118944, 2020 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870952
9.
Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations.
J Control Release
; 325: 1-9, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32598958
10.
Antiadhesion effect of the C17 glycerin ester of isoprenoid-type lipid forming a nonlamellar liquid crystal.
Acta Biomater
; 84: 257-267, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529080
11.
A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C17-Monoglycerol Ester Liquid Crystal-forming Lipid.
J Oleo Sci
; 66(5): 443-454, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381773
12.
Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.
J Oleo Sci
; 66(9): 939-950, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867759
13.
PE859, A Novel Curcumin Derivative, Inhibits Amyloid-ß and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
J Alzheimers Dis
; 59(1): 313-328, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598836
14.
Topical application of toll-like receptor 3 inhibitors ameliorates chronic allergic skin inflammation in mice.
J Dermatol Sci
; 101(2): 141-144, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262024
15.
PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
PLoS One
; 10(2): e0117511, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25659102